netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 19 of 19


Details
UPD sitematrix Changed from 0 to
20/11/2023 12:41:57
(DavidS )
UPD FurtherInformation Changed from
  • Approved for use in the treatment of renal cell carcinoma in line with NICE and NHS England Commissioning Policy
20/11/2023 12:41:57
(DavidS )
UPD Cabozantinib (Cometriq®) updated formatting
20/11/2023 12:41:57
(DavidS )
UPD sitematrix Changed from 0 to
11/07/2023 17:18:35
(dmcdermott )
UPD FurtherInformation Changed from
11/07/2023 17:18:35
(dmcdermott )
UPD Cabozantinib (Cometriq®) =
11/07/2023 17:18:35
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (July 2020): Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection : https://www.gov.uk/drug-safety-update/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-arte
11/07/2023 17:17:57
(dmcdermott )
LDL Link Added : NICE TA849: Cabozantinib for previously treated advanced hepatocellular carcinoma : https://www.nice.org.uk/guidance/ta849
04/07/2023 12:14:37
(rpaylor )
LDL Link Added : NICE TA 542: Cabozantinib for untreated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta542
24/01/2019 15:27:23
(DavidS )
UPD Cabozantinib (Cometriq®) NICE TA542
24/01/2019 15:26:43
(DavidS )
UPD Published from Draft Mode
09/05/2018 10:59:07
(LoweryM )
UPD Cabozantinib (Cometriq®) approved
09/05/2018 10:58:33
(LoweryM )
LDL Link Added : NICE TA516: Cabozantinib for treating medullary thyroid cancer : https://www.nice.org.uk/guidance/ta516
27/04/2018 14:19:54
(DavidS )
UPD Cabozantinib (Cometriq®) NICE TA516 approved at APC (April 2018)
27/04/2018 14:19:23
(DavidS )
UPD Published from Draft Mode
27/10/2017 15:02:24
(DavidS )
UPD Cabozantinib (Cometriq®) updated
27/10/2017 15:02:11
(DavidS )
LDL Link Added : NICE TA463 Cabozantinib for previously treated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta463
26/10/2017 13:36:03
(DavidS )
UPD Cabozantinib (Cometriq®) NICE TA463
26/10/2017 13:16:39
(DavidS )
UPD Status Changed to | Hidden | Published
22/03/2017 15:10:45
(DavidS )

 

 

netFormulary